Sentence examples for progression of complex from inspiring English sources
Biomarkers are the key missing link in researchers' ability to test new treatments that could slow or stop the progression of complex neurological diseases like Alzheimer's and Parkinson's (something no current therapy can do).
To understand the progression of complex diseases such as cancer, scientists have had to tease out the interactions between cells at progressively finer scales — from the behavior of a single tumor cell in the body on down to the activity of that cell's inner machinery.
Epistasis, i.e., the interaction of alleles at different loci, is thought to play a central role in the formation and progression of complex diseases.
In the wider population, differential DNA methylation may similarly contribute to the diversity of phenotypes, pathogenesis and progression of complex diseases.
We found that the temporal progression of complex I deficiency differed across tissues and that the involvement of each tissue correlated with the residual amount of complex I 20 kDa subunit.
More recently, a growing body of new evidence has indicated that chromatin variation, such as differential DNA methylation, independent of DNA sequence changes, may play an important role in regulating the phenotypic formation and progression of complex traits [9] [12].
Recently, metabolic analysis technologies, such as FVA, could offer excellent insights into the development and progression mechanism of complex diseases.
From far to near, the picture shows progression of the complex formation between FGFR1 and PLCγ.
The future of treating this disease therefore lies in increasing understanding of the mutations which cause tumourigenesis, and insight into the development and progression of this complex disease.
To describe a case of progression of endometrial complex atypical hyperplasia (CAH) to extrauterine endometrioid adenocarcinoma in a patient who had requested fertility-sparing management.
With the progress of system biology and bionetwork, we know that the biological potency of an ideal drug may not merely determined by the inhibition of a single target, but rather by the rebalancing of several proteins or events, which contribute to the etiology, pathogeneses, and progression of a complex disease [13] [26].
